Phenylketonuria Market Size, Scope, Emerging Technologies, & Booming Growth 2022-2028 Forecast, Demand, Key Players, Restraints
The phenylketonuria market is expected to gain market growth in
the forecast period till 2028. Data Bridge Market Research analyses that the
market is growing with the CAGR of 8.98% in the forecast period till 2028 and
is estimated to reach 1041.01 USD million by 2028. This phenylketonuria market report
provides details of new recent developments, trade regulations, import export
analysis, production analysis, value chain optimization, market share, impact
of domestic and localised market players, analyses opportunities in terms of
emerging revenue pockets, changes in market regulations, strategic market
growth analysis, market size, category market growths, application niches and
dominance, product approvals, product launches, geographic expansions,
technological innovations in the market. To gain more info on phenylketonuria
market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an
informed market decision to achieve market growth.
Sample
copy of report- https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-phenylketonuria-market
Phenylketonuria
is an inborn error of metabolism that is detectable during the first days of
life via routine newborn screening. Phenylketonuria is characterized by the
absence or deficiency of an enzyme called phenylalanine hydroxylase (PAH),
responsible for processing the amino acid phenylalanine. Amino acids are the
chemical building blocks of proteins and are essential for proper growth and
development. With normal PAH activity, phenylalanine is converted to another
amino acid, tyrosine. However, when PAH absent or deficient, phenylalanine
accumulates and is toxic to the brain. Without treatment, most people with
Phenylketonuria would develop a severe intellectual disability. To prevent
intellectual disability, treatment consists of a carefully controlled,
phenylalanine-restricted diet beginning during the first days or weeks of life.
Phenylketonuria is inherited in families in
an autosomal recessive pattern. Autosomal recessive inheritance means that a
person has two copies of the gene that is altered. Usually, each parent of an
individual who has Phenylketonuria carries one copy of the altered gene. Since
each parent also has a normal gene, they do not show signs or symptoms of
Phenylketonuria.
Full
asceses of report- https://www.databridgemarketresearch.com/reports/global-phenylketonuria-market
Ø Chapter
One: Introduction
Ø Chapter
Two: Market Segmentation
Ø Chapter
Three: Market Overview
Ø Chapter
Four: Executive Summary
Ø Chapter
Five: Premium Insights
TOC
Details:
https://www.databridgemarketresearch.com/toc/?dbmr=global-phenylketonuria-market
The
major players covered in the phenylketonuria market report are DAIICHI SANKYO
COMPANY, LIMITED, Ajinomoto Cambrooke, Inc., American Gene Technologies,
Ultragenyx Pharmaceutical, Nutricia, Homology Medicines, Inc., Reckitt Benckiser
Group plc, Abbott, Travere Therapeutics, Inc., Synlogic, Promin., SOM BIOTECH,
S.L. Healthcare, Synthetic Biologics,
Inc., Nestlé, Codexis, BioMarin, Erytech Pharma., Censa Pharmaceutical
Inc., Rubius Therapeutics, Inc., among other domestic and global players.
Market share data is available for global, North America, Europe, Asia-Pacific
(APAC), Middle East and Africa (MEA) and South America separately.
Q1. Which is the most
lucrative country for phenylketonuria treatment?
The U.S., at present, holds the maximum market share
and leads the global phenylketonuria treatment market. The U.S. is expected to
experience significant demand for phenylketonuria treatment over the entire
forecast period.
Q2. Which ingredient holds a
significant share in the market?
Essential and non-essential amino acids hold the highest
market share of one-third. These continue to dominate the market based on
protein ingredient as well as finished product.
Q3. Which form of PKU ingredient
is expected to dominate phenylketonuria treatment?
Based on protein ingredient, the powder blend form
accounted for the highest share, while based on finished product, powder and
the granule forms accounted for high shares in the phenylketonuria treatment
market.
Q4. Which are the leading
companies in phenylketonuria treatment market?
Some of the prominent companies offering
phenylketonuria treatment are for protein ingredients - Arla Foods Ingredients
Group P/S, Archer Daniels Midland Company, BASF SE, Chr. Hansen, Cargill,
Incorporated, Seidler Chemical Co, Inc. Additionally for the finish products
for PKU treatment the manufacturers include- Nestlé S.A. (Vitaflo
International), Reckitt Benckiser Group plc. (Mead Johnson & Company,
LLC.), Abbott Laboratories, APR Applied Pharma Research S. A., Ajinomoto Co.,
Inc., VitafriendsPKU, Pristine Organics Pvt. Ltd., and others.
Q5. What are the restraining
factors phenylketonuria treatment?
Challenges associated can be the high cost of PKU
treatment, inconsistent reimbursement policies, and lack of treatment regimen
compliance.
Profound Questions Answered in this Report:
·
What is
the growth rate of various stages in the value chain of the industry?
·
Which
region has the highest growth rate and size of the emerging market by value in
2021?
·
Who are
the competitive players in point of care (POC)
lipid test market?
·
Which
region has the largest share and degree of competition in the industry?
·
What is
the CAGR of the market during the forecast period 2021 to 2027?
·
Which
region is expected to hold the highest market share for the market?
·
What is
the main driver of the point of care (POC) lipid test market?
·
What is
sales volume, revenue, and price analysis of top players of the market?
·
What are
the market opportunities and threats faced by the vendors in the industry?
·
What has
been the impact of COVID-19 on the point of care (POC)
lipid test market?
Point of Care (PoC) Lipid Test Market
Pregnancy Care Products Market
Data
Bridge Market Research set forth itself as an unconventional
and neoteric Market research and consulting firm with unparalleled level of
resilience and integrated approaches. We are determined to unearth the best
market opportunities and foster efficient information for your business to
thrive in the market
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
Comments
Post a Comment